Related references
Note: Only part of the references are listed.Real-world data: towards achieving the achievable in cancer care
Christopher M. Booth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Real-world evidence was feasible for estimating effectiveness of chemotherapy in breast cancer: a cohort study
Ewan Gray et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Biases in electronic health record data due to processes within the healthcare system: retrospective observational study
Denis Agniel et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Biases in electronic health record data due to processes within the healthcare system: retrospective observational study
Denis Agniel et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data
Ewan Gray et al.
BRITISH JOURNAL OF CANCER (2018)
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
Francisco J. Candido dos Reis et al.
BREAST CANCER RESEARCH (2017)
OPTIMA: a prospective randomised trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions
Robert Stein et al.
EJSO (2016)
Incorporating Both Randomized and Observational Data into a Single Analysis
Eloise E. Kaizar
ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, VOL 2 (2015)
Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2-positive patients with early-stage breast cancer
Sue K. Down et al.
ONCOLOGY LETTERS (2014)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?
R. Leonard et al.
BRITISH JOURNAL OF CANCER (2011)
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
Joseph V. Terza et al.
JOURNAL OF HEALTH ECONOMICS (2008)
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
Merrick Zwarenstein et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Use and outcomes of adjuvant chemotherapy in older women with breast cancer
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
PM Ravdin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
